The glycoprotein (GP) of Ebola is the sole structural protein that forms the spikes on the viral envelope. The GP contains two subunits, GP1 and GP2, linked by a disulfide bond, which are responsible for receptor binding and membrane fusion, respectively. In this study, the full length of GP gene of Ebola Zaire species, 2028 base pairs in length, was synthesized using 38 overlapping oligonucleotides by multiple rounds of polymerase chain reaction (PCR). The synthesized GP gene was shown to be efficiently expressed in mammalian cells. Furthermore, an efficient HIV-based pseudotyping system was developed using the synthetic GP gene, providing a safe approach to dissecting the entry mechanism of Ebola viruses. Using this pseudotyping system and mutational analysis, the role of the charged residues in the GP2 helical regions was examined. It was found that substitutions of the most charged residues in the regions did not adversely affect GP expression, processing, or viral incorporation, however, most of the mutations greatly impaired the ability of GP to mediate efficient viral infection. These results demonstrate that these charged residues of GP2 play an important role in GP-mediated Ebola entry into its host cells. We propose that these charged residues are involved in forming the intermediate conformation(s) of GP in membrane fusion and Ebola entry.
Bachelder R E, Bilancieri J, Lin W,et al. 1995. A human recombinant Fab identifies a human immunodeficiency virus type 1-induced conformational change in cell surface-expressed CD4. J Virol, 69:5734–5742.
Baker K A, Dutch R E, Lamb R A,et al. 1999. Structural basis for paramyxovirus-mediated membrane fusion. Mol Cell, 3:309–319.
Bisht H, Roberts A, Vogel L,et al. 2004. Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice. Proc Natl Acad Sci USA, 101:6641–6646.
Brindley M A, Hughes L, Ruiz A,et al. 2007. Ebola virus glycoprotein 1: identification of residues important for binding and postbinding events. J Virol, 81:7702–7709.
Bullough P A, Hughson F M, Skehel J J,et al. 1994. Structure of influenza haemagglutinin at the pH of membrane fusion. Nature, 371:37–43.
Caffrey M. 2001. Model for the structure of the HIV gp41 ectodomain: insight into the intermolecular interactions of the gp41 loop. Biochim Biophys Acta, 1536:116–122.
Carr C M, Kim P S. 1993. A spring-loaded mechanism for the conformational change of influenza hemagglutinin. Cell, 73:823–832.
Colman P M, Lawrence M C. 2003. The structural biology of type I viral membrane fusion. Nat Rev Mol Cell Biol, 4:309–319.
Connor R I, Chen B K, Choe S,et al. 1995. Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes. Virology, 206:935–944.
Fass D, Blacklow S C, Kim P S. 1996. Retrovirus envelope domain at 1.7A0 resolution. Nature Struct Biol, 3:465–469.
Gallaher W R. 1996. Similar structural models of the transmembrane proteins of Ebola and avian sarcoma viruses. Cell, 85:477–478.
Higginbottom A, Quinn E R, Kuo C C,et al. 2000. Identification of amino acid residues in CD81 critical for interaction with hepatitis C virus envelope glycoprotein E2 [In Process Citation]. J Virol, 74:3642–3649.
Jeffers S A, Sanders D A, Sanchez A. 2002. Covalent modifications of the ebola virus glycoprotein. J Virol, 76:12463–12472.
Kao C C, Yang X, Kline A,et al. 2000. Template Requirements for RNA Synthesis by a Recombinant Hepatitis C Virus RNA-Dependent RNA Polymerase. J Virol, 74:11121–11128.
Kuhn J H, Radoshitzky S R, Guth A C,et al. 2006. Conserved receptor-binding domains of Lake Victoria marburgvirus and Zaire ebolavirus bind a common receptor. J Biol Chem, 281:15951–15958.
Lee J E, Fusco M L, Hessell A J,et al. 2008. Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor. Nature, 454:177–182.
Ma M, Kersten D B, Kamrud K I,et al. 1999. Murine leukemia virus pseudotypes of La Crosse and Hantaan Bunyaviruses: a system for analysis of cell tropism. Virus Res, 64:23–32.
Malashkevich V N, Chan D C, Chutkowski C T,et al. 1998. Crystal structure of the simian immunodeficiency virus (SIV) gp41 core: conserved helical interactions underlie the broad inhibitory activity of gp41 peptides. Proc Natl Acad Sci U S A, 95:9134–9139.
Malashkevich V N, Schneider B J, McNally M L,et al. 1999. Core structure of the envelope glycoprotein GP2 from Ebola virus at 1.9-A resolution. Proc Natl Acad Sci USA, 96:2662–2667.
Manicassamy B, Wang J, Jiang H,et al. 2005. Comprehensive Analysis of Ebola Virus GP1 in Viral Entry. J Virol, 79:4793–4805.
Manicassamy B, Wang J, Rumschlag E,et al. 2007. Characterization of Marburg virus glycoprotein in viral entry. Virology, 358:79–88.
Medina M F, Kobinger G P, Rux J,et al. 2003. Lentiviral vectors pseudotyped with minimal filovirus envelopes increased gene transfer in murine lung. Mol Ther, 8:777–789.
Mpanju O M, Towner J S, Dover J E,et al. 2006. Identification of two amino acid residues on Ebola virus glycoprotein 1 critical for cell entry. Virus Res, 121:205–214.
Neumann G, Feldmann H, Watanabe S,et al. 2002. Reverse genetics demonstrates that proteolytic processing of the Ebola virus glycoprotein is not essential for replication in cell culture. J Virol, 76:406–410.
Prehaud C, Hellebrand E, Coudrier D,et al. 1998. Recombinant Ebola virus nucleoprotein and glycoprotein (Gabon 94 strain) provide new tools for the detection of human infections. J Gen Virol, 79(Pt 11):2565–2572.
Rong L, Bates P. 1995. Analysis of the subgroup A avian sarcoma and leukosis virus receptor: the 40-residue, cysteine-rich, low-density lipoprotein receptor repeat motif of Tva is sufficient to mediate viral entry. J Virol, 69:4847–4853.
Rong L, Gendron K, Strohl B,et al. 1998. Characterization of determinants for envelope binding and infection in Tva, the subgroup A avian sarcoma and leukosis virus receptor. J Virol, 72:4552–4559.
Russell C J, Kantor K L, Jardetzky T S,et al. 2003. A dual-functional paramyxovirus F protein regulatory switch segment: activation and membrane fusion. J Cell Biol, 163:363–374.
Sanchez A, Khan A S, Zaki S R,et al. 2001. Filoviridae: Marburg and Ebola Viruses. In: Fields Virology (Knipe D M, Howley P M. ed.), 4th ed, vol. 1. Lippicott Williams & Wilkins, Philadelphia, PA. p1279–1304.
Sanchez A, Kiley M P, Holloway B P,et al. 1993. Sequence analysis of the Ebola virus genome: organization, genetic elements, and comparison with the genome of Marburg virus. Virus Res, 29:215–240.
Sanchez A, Trappier S G, Mahy B W,et al. 1996. The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing. Proc Natl Acad Sci USA, 93:3602–3607.
Sanchez A, Trappier S G, Stroher U,et al. 1998. Variation in the glycoprotein and VP35 genes of Marburg virus strains. Virology, 240:138–146.
Simmons G, Wool-Lewis R J, Baribaud F,et al. 2002. Ebola virus glycoproteins induce global surface protein down-modulation and loss of cell adherence. J Virol, 76:2518–2528.
Takada A, Feldmann H, Stroeher U,et al. 2003. Identification of protective epitopes on ebola virus glycoprotein at the single amino acid level by using recombinant vesicular stomatitis viruses. J Virol, 77:1069–1074.
Takada A, Robison C, Goto H,et al. 1997. A system for functional analysis of Ebola virus glycoprotein. Proc Natl Acad Sci USA, 94:14764–14769.
Volchkov V E, Becker S, Volchkova V A,et al. 1995. GP mRNA of Ebola virus is edited by the Ebola virus polymerase and by T7 and vaccinia virus polymerases. Virology, 214:421–430.
Volchkov V E, Blinov V M, Netesov S V. 1992. The envelope glycoprotein of Ebola virus contains an immunosuppressive-like domain similar to oncogenic retroviruses. FEBS Lett, 305:181–184.
Weissenhorn W, Dessen A, Harrison S C,et al. 1997. Atomic structure of the ectodomain from HIV-1 gp41. Nature, 387:426–430.
Weissenhorn W, Calder L J, Wharton S A,et al. 1998. The central structural feature of the membrane fusion protein subunit from the Ebola virus glycoprotein is a long triple-stranded coiled coil. Proc Natl Acad Sci USA, 95:6032–6036.
Wilson I A, Skehel J J, Wiley D C. 1981. Structure of the hemagglutinin membrane glycoprotein of influenza virus at 3A resolution. Nature, 289:366–373.
Foundation items: The laboratory research was supported by National Institutes of Health grants CA 092459 and AI48056. L. R. was a recipient of the Schweppe Foundation Career Development Award.
Rights and permissions
About this article
Cite this article
Jiang, H., Wang, J., Manicassamy, B. et al. The role of the charged residues of the GP2 helical regions in Ebola entry. Virol. Sin. 24, 121–135 (2009). https://doi.org/10.1007/s12250-009-3015-6
- Ebola virus
- Glycoprotein GP1/GP2
- Charged residues
- Viral entry